{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import xml.etree.ElementTree as ET\n",
    "import pandas as pd\n",
    "from rdflib import Graph, URIRef, Literal, Namespace\n",
    "from rdflib.namespace import RDF, RDFS\n",
    "from dotenv import load_dotenv\n",
    "from urllib.parse import unquote\n",
    "from rdflib.tools.rdf2dot import rdf2dot\n",
    "import pydot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "class Study:\n",
    "    def __init__(self, file_id, title, condition):\n",
    "        self.file_id = file_id\n",
    "        self.title= title\n",
    "        self.condition = condition\n",
    "\n",
    "class Drug:\n",
    "    def __init__(self, name):\n",
    "        self.name = name\n",
    "        self.moa_urls = []\n",
    "        self.act_urls = []\n",
    "        self.files = []\n",
    "        self.mesh_info = None\n",
    "        self.struct_id = None\n",
    "\n",
    "\n",
    "class MeshElement:\n",
    "    def __init__(self, descriptor_name, descriptor_ui):\n",
    "        self.descriptor_name = descriptor_name\n",
    "        self.descriptor_ui = descriptor_ui"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load the environment variables from the .env file\n",
    "load_dotenv()\n",
    "\n",
    "xml_folder_path = os.getenv('FOLDER')\n",
    "tsv_file = os.getenv('FILE_TSV')\n",
    "MeSH_file = os.getenv('MeSH')\n",
    "\n",
    "# RDF graph\n",
    "graph = Graph()\n",
    "\n",
    "# Define RDF namespaces and bind\n",
    "CT = Namespace(\"https://clinicaltrials.gov/\")\n",
    "DRUG_CARD = Namespace(\"https://drugcentral.org/drugcard/\")\n",
    "SCHEMA = Namespace(\"https://schema.org/\")\n",
    "STUDY = Namespace(\"https://clinicaltrials.gov/ct2/show/\")\n",
    "MESH = Namespace(\"https://www.ncbi.nlm.nih.gov/mesh/?term=\")\n",
    "\n",
    "graph.bind('ct', CT)\n",
    "graph.bind('drug', DRUG_CARD)\n",
    "graph.bind('file', STUDY)\n",
    "graph.bind('mesh', MESH)\n",
    "graph.bind('schema', SCHEMA)\n",
    "\n",
    "context = {\n",
    "    \"ct\": \"https://clinicaltrials.gov/\",\n",
    "    \"drug\": \"https://drugcentral.org/drugcard/\",\n",
    "    \"file\": \"https://clinicaltrials.gov/ct2/show/\",\n",
    "    \"mesh\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=\",\n",
    "    \"schema\": \"https://schema.org/\"\n",
    "}\n",
    "\n",
    "# Add the context to your RDF graph\n",
    "graph.namespace_manager.context = context\n",
    "\n",
    "# Dictionary to store information associated with each drug\n",
    "drugs_info = {}\n",
    "\n",
    "# Set to store drugs not present in the TSV\n",
    "missing_drugs = set()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Iterate over all XML studies files\n",
    "for filename in os.listdir(xml_folder_path):\n",
    "    if filename.endswith('.xml'):\n",
    "        xml_file_path = os.path.join(xml_folder_path, filename)\n",
    "\n",
    "        tree = ET.parse(xml_file_path)\n",
    "        root = tree.getroot()\n",
    "\n",
    "        # Extract information from the XML file\n",
    "        intervention_type = root.find('.//intervention_type')\n",
    "        intervention_name = root.find('.//intervention_name')\n",
    "\n",
    "        # Check if the intervention_type field is \"drug\"\n",
    "        if intervention_type is not None and intervention_type.text.lower() == 'drug':\n",
    "            # Initialize the drug object if it does not exist\n",
    "            drug_name = intervention_name.text.lower()\n",
    "            drug_name_uri = '_'.join(drug_name.split())\n",
    "\n",
    "            \n",
    "\n",
    "            if root.find('.//official_title') is not None:\n",
    "                study_title = root.find('.//official_title').text\n",
    "            else:\n",
    "                study_title = root.find('.//brief_title').text\n",
    "                \n",
    "            study_condition = root.find('.//condition').text\n",
    "\n",
    "            if drug_name_uri not in drugs_info:\n",
    "                drugs_info[drug_name_uri] = Drug(drug_name)\n",
    "\n",
    "            # Add the current file to the list of files associated with the drug\n",
    "            drugs_info[drug_name_uri].files.append(Study(filename, study_title, study_condition))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read the TSV file with drug information\n",
    "with open(tsv_file, 'r') as tsv_file:\n",
    "    tsv_data = pd.read_csv(tsv_file, delimiter='\\t')\n",
    "\n",
    "# Filter the data to include only drugs mentioned in the XML files\n",
    "tsv_data = tsv_data[tsv_data['DRUG_NAME'].str.lower().isin(drugs_info.keys())]\n",
    "\n",
    "# Iterate over drugs in the XML files\n",
    "for index, row in tsv_data.iterrows():\n",
    "    drug_name = row['DRUG_NAME']\n",
    "    moa_source_url = row['MOA_SOURCE_URL']\n",
    "    act_source_url = row['ACT_SOURCE_URL']\n",
    "    struct_id = row['STRUCT_ID']\n",
    "\n",
    "    # Replace spaces with underscores to create valid URIs\n",
    "    drug_name_uri = '_'.join(drug_name.split())\n",
    "\n",
    "    # Normalize URLs\n",
    "    moa_source_url = unquote(str(moa_source_url))\n",
    "    act_source_url = unquote(str(act_source_url))\n",
    "\n",
    "    # Add information to the Drug object for the drug\n",
    "    if drug_name_uri in drugs_info:\n",
    "        drug_obj = drugs_info[drug_name_uri]\n",
    "\n",
    "        # Append MOA URLs and ACT URLs to the Drug object\n",
    "        drug_obj.moa_urls.append(Literal(moa_source_url) if not pd.isna(moa_source_url) else Literal(None))\n",
    "        drug_obj.act_urls.append(Literal(act_source_url) if not pd.isna(act_source_url) else Literal(None))\n",
    "\n",
    "        # Set the struct_id for the Drug object\n",
    "        drug_obj.struct_id = struct_id\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read the MeSH XML file\n",
    "mesh_tree = ET.parse(MeSH_file)\n",
    "mesh_root = mesh_tree.getroot()\n",
    "\n",
    "for drug_name_uri, drug_info in drugs_info.items():\n",
    "    drug_name = drug_name_uri.replace('_', ' ')\n",
    "    struct_id = drug_info.struct_id\n",
    "\n",
    "    # Search for drug_name in MeSH XML\n",
    "    for descriptor_record in mesh_root.findall('.//DescriptorRecord'):\n",
    "        descriptor_name = descriptor_record.find('.//DescriptorName/String')\n",
    "        if descriptor_name is not None and descriptor_name.text.lower() == drug_name.lower():\n",
    "            # Drug found in MeSH XML, extract information\n",
    "            descriptor_ui = descriptor_record.find('.//DescriptorUI')\n",
    "            if descriptor_ui is not None:\n",
    "                # Create MeshElement instance and add MeSH information to the Drug object\n",
    "                mesh_element = MeshElement(descriptor_name.text, descriptor_ui.text)\n",
    "                drug_info.mesh_info = mesh_element\n",
    "                break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "for drug_name_uri, info in drugs_info.items():\n",
    "    # Check if the drug is missing in the TSV\n",
    "    if drug_name_uri not in [name.lower().replace(' ', '_') for name in tsv_data['DRUG_NAME']]:\n",
    "        missing_drugs.add(drug_name_uri)\n",
    "        continue\n",
    "\n",
    "    drug = Drug(drug_name_uri.replace('_', ' '))\n",
    "    drug_uri = URIRef(DRUG_CARD[repr(info.struct_id)]) \n",
    "\n",
    "    graph.add((drug_uri, RDF.type, SCHEMA.Drug))\n",
    "    graph.add((drug_uri, RDFS.label, Literal(drug.name)))\n",
    "\n",
    "    # Handling MOA URLs\n",
    "    for moa_url in info.moa_urls:\n",
    "        if moa_url.lower() != 'nan':\n",
    "            drug.moa_urls.append(Literal(moa_url))\n",
    "            graph.add((drug_uri, SCHEMA.url, Literal(moa_url)))\n",
    "\n",
    "    # Handling ACT URLs\n",
    "    for act_url in info.act_urls:\n",
    "        if act_url.lower() != 'nan':\n",
    "            drug.act_urls.append(Literal(act_url))\n",
    "            graph.add((drug_uri, SCHEMA.url, Literal(act_url)))\n",
    "\n",
    "    # Connecting files to the drug node\n",
    "    for doc in info.files:\n",
    "        file_id = doc.file_id[:-4]\n",
    "        study = Study(file_id, doc.title, doc.condition)\n",
    "        file_uri = URIRef(STUDY[file_id])\n",
    "\n",
    "        graph.add((file_uri, RDF.type, SCHEMA.MedicalStudy))\n",
    "        graph.add((file_uri, RDFS.label, Literal(study.title)))\n",
    "        graph.add((file_uri, SCHEMA.MedicalCondition, Literal(study.condition)))\n",
    "        graph.add((drug_uri, SCHEMA.study, file_uri))\n",
    "\n",
    "\n",
    "    # Adding MeSH information\n",
    "    mesh_info = info.mesh_info\n",
    "    if mesh_info is not None and isinstance(mesh_info, MeshElement):\n",
    "        descriptor_uri = URIRef(MESH[mesh_info.descriptor_ui])\n",
    "        graph.add((drug_uri, SCHEMA.url, descriptor_uri))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "    \"@context\": {\n",
      "        \"ct\": \"https://clinicaltrials.gov/\",\n",
      "        \"drug\": \"https://drugcentral.org/drugcard/\",\n",
      "        \"file\": \"https://clinicaltrials.gov/ct2/show/\",\n",
      "        \"mesh\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=\",\n",
      "        \"schema\": \"https://schema.org/\"\n",
      "    },\n",
      "    \"@graph\": [\n",
      "        {\n",
      "            \"@id\": \"drug:939\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"docetaxel\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015886\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017563\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014352\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010140\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545252\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077143\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1255\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"fulvestrant\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012025\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010153\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077267\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1277\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"ganciclovir\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00016068\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D015774\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015704\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"An Open-Label, Pilot Study Utilizing CD4 T-Cell Counts Lower Than 350 Cells/mm3 as the Threshold for Restarting Therapy With Potent Antiretroviral Therapy With or Without Interleukin-2 to Determine the Effect of Pulse Therapy on the Characteristics of Treatment Interruptions\",\n",
      "            \"schema:MedicalCondition\": \"HIV Infections\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2303\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"propranolol\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00016666\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016419s029lbl.pdf\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D011433\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1209\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"fluoxetine\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018902\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018174\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00011765\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D005473\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016302\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"The Use of Modified BFM +/- Compound 506U78 (Nelarabine) (NSC# 686673, IND #52611) in an Intensive Chemotherapy Regimen for the Treatment of T-Cell Leukemia\",\n",
      "            \"schema:MedicalCondition\": \"T-cell Childhood Acute Lymphoblastic Leukemia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010088\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas\",\n",
      "            \"schema:MedicalCondition\": \"Extrahepatic Bile Duct Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015821\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Pilot Study of Thalidomide as an Inhibitor of Angiogenesis in the Treatment of Myelofibrosis With Myeloid Metaplasia (MMM)\",\n",
      "            \"schema:MedicalCondition\": \"Primary Myelofibrosis\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012038\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas\",\n",
      "            \"schema:MedicalCondition\": \"Brain and Central Nervous System Tumors\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016081\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Phase III Study To Evaluate The Safety And Efficacy Or Ribavirin Inhaled Solution In Preventing Progression Of Upper Respiratory Tract Respiratory Syncytial Virus (RSV) Infection To RSV Pneumonia In Blood And Bone Marrow Transplant (BMT) Recipients\",\n",
      "            \"schema:MedicalCondition\": \"Infection\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:435\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"bupropion\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018187\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D016642\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019539\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Randomized Study of Monoclonal Antibody VEGF in Patients With Unresectable Advanced Renal Cell Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Stage IV Renal Cell Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014404\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Double-Blind, Placebo Controlled, Randomized Study Of Celecoxib, A Selective COX-2 Inhibitor, In Oral Premalignant Lesions\",\n",
      "            \"schema:MedicalCondition\": \"Head and Neck Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015106\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019240\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI'S SARCOMA (KS)\",\n",
      "            \"schema:MedicalCondition\": \"Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2616\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"thalidomide\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015821\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014443\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016224\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019747\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019123\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015990\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/26131937\",\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/25043012\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D013792\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019513\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients\",\n",
      "            \"schema:MedicalCondition\": \"Colorectal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018187\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Combinations of Pharmacologic Smoking Cessation Treatments\",\n",
      "            \"schema:MedicalCondition\": \"Smoking\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017199\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of PS-341 in Metastatic Neuroendocrine Tumors\",\n",
      "            \"schema:MedicalCondition\": \"Gastrointestinal Carcinoid Tumor\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010387\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease\",\n",
      "            \"schema:MedicalCondition\": \"Anemia, Hemolytic, Autoimmune\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:348\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"betamethasone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015002\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL632\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D001623\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014443\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Pilot Study Of Hycamtin (Topotecan) And Thalomid (Thalidomide) In Patients With Recurrent Malignant Gliomas\",\n",
      "            \"schema:MedicalCondition\": \"Brain and Central Nervous System Tumors\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1765\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"naltrexone\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018824\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015080\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D009271\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018291\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Specific Interventions for Agitation in Alzheimer's Disease\",\n",
      "            \"schema:MedicalCondition\": \"Alzheimer's Disease\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016328\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study of CCI-779 in Patients With Recurrent Glioblastoma Multiforme\",\n",
      "            \"schema:MedicalCondition\": \"Adult Giant Cell Glioblastoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010140\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Multicenter Randomized Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018161\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Combined Pharmacologic/Behavioral Treatment for Smoking Cessation\",\n",
      "            \"schema:MedicalCondition\": \"Smoking\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017030\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of ET-743 Given as a Three Hour Intravenous Infusion in Patients With Advanced and/or Metastatic Soft Tissue Sarcoma Previously Treated With Chemotherapy\",\n",
      "            \"schema:MedicalCondition\": \"Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1678\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"melphalan\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017680\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019968\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D008558\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:588\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"chlorambucil\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017108\"\n",
      "            },\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002699\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1539\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"lamivudine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017719\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D019259\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1513\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"itraconazole\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00012467\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22587\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D017964\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015002\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Placebo-Controlled Trial of Antenatal Corticosteroid Regimens\",\n",
      "            \"schema:MedicalCondition\": \"Complications, Pregnancy\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015054\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"MPD04961-Methylphendidate Treatment of Cocaine Dependent ADHD Patients\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015249\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Prepulse Inhibition of Startle in Cocaine Dependence (Human)\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:5015\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"pegvisomant\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017927\"\n",
      "            },\n",
      "            \"schema:url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021106s036lbl.pdf\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:254\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"atazanavir\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00013897\"\n",
      "            },\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016965\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Pancreatic Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014638\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Open Label, Multicenter Trial Of Femera (Letrozole) 2.5 mg As First-line Therapy In Postmenopausal Women With Metastatic Breast Cancer Relapsing Following Adjuvant Tamoxifen Therapy\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:770\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"cytarabine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00016016\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D003561\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010062\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Study Of Post-Operative Concomitant Radio-Chemotherapy With A Continuous Infusion Of Flourouracil For Adjuvant Treatment Of Resected Pancreatic Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Pancreatic Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016666\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Treatment of Winter Depression With Pharmacological Suppression of Melatonin Secretion\",\n",
      "            \"schema:MedicalCondition\": \"Seasonal Affective Disorder\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018382\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach\",\n",
      "            \"schema:MedicalCondition\": \"Alzheimer Disease\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016926\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Limited Access Phase II Trial Of Capecitabine In Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix\",\n",
      "            \"schema:MedicalCondition\": \"Cervical Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:391\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"bortezomib\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017199\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017329\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00011778\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000069286\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:5414\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"lonafarnib\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015899\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213969s000lbl.pdf\",\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/10377218\"\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2113\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"perphenazine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00014001\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D010546\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016224\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Trial of Thalidomide in Patients With Ovarian Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Ovarian Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017680\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in\",\n",
      "            \"schema:MedicalCondition\": \"Amyloidosis\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012220\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Phase II Study Of Gemcitabine/Cisplatin, Gemcitabine/Docetaxel, Gemcitabine/Irinotecan, Or Fixed Dose Rate Infusion Gemcitabine In Patients With Metastic Pancreatic Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Pancreatic Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1971\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"nortriptyline\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018148\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445\",\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/17071817\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D009661\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:4119\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"romidepsin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019318\"\n",
      "            },\n",
      "            \"schema:url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022393s013lbl.pdf\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2436\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"sertraline\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015132\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D020280\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014729\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa\",\n",
      "            \"schema:MedicalCondition\": \"Epidermolysis Bullosa\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014469\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies\",\n",
      "            \"schema:MedicalCondition\": \"Graft Versus Host Disease\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:960\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"doxorubicin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017160\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D004317\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015665\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Open-Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents\",\n",
      "            \"schema:MedicalCondition\": \"Mycoses\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014352\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Trial Of Sequential Estramustine/Paclitaxel Followed By Doxorubicin/Ketoconazole In Patients With Androgen-Independent Prostate Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Prostate Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012090\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Trial Of Oral Bicalutamide With Subcutaneous Goserelin In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Carcinoma In Second Or Greater Remission\",\n",
      "            \"schema:MedicalCondition\": \"Fallopian Tube Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017628\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis\",\n",
      "            \"schema:MedicalCondition\": \"Multiple Sclerosis\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018733\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Biological Aspects of Depression and Antidepressant Drugs\",\n",
      "            \"schema:MedicalCondition\": \"Depression\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016991\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study of ZD 1839 (NSC 715055) for Patients With First Relapse Glioblastoma Multiforme\",\n",
      "            \"schema:MedicalCondition\": \"Brain and Central Nervous System Tumors\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:692\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"clofazimine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018044\"\n",
      "            },\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002991\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018668\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Psychopharmacologic Aspects of Motor Slowing in Schizophrenia\",\n",
      "            \"schema:MedicalCondition\": \"Schizophrenia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010400\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome\",\n",
      "            \"schema:MedicalCondition\": \"Systemic Lupus Erythematosus\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014144\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II\",\n",
      "            \"schema:MedicalCondition\": \"Bladder Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016068\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase III Multicenter Study Of Valganciclovir For The Prevention Of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation\",\n",
      "            \"schema:MedicalCondition\": \"Infection\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014209\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study Of Gemcitabine, Dexamethasone, And Cisplatin (GDP) In Patients With Either Hodgkin's Disease Or Aggressive Histology Non-Hodgkin's Lymphoma Which Is Relapsed Or Refractory\",\n",
      "            \"schema:MedicalCondition\": \"Lymphoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1992\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"ondansetron\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018850\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D017294\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2253\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"prednisone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00016302\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL635\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D011241\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017459\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"The International Tirazone Triple Trial (i3T): A Phase III, Randomized Efficacy And Safety Study Of The Combination Chemotherapy With Tirapazamine+Cisplatin+Vinorelbine Versus Cisplatin+Vinorelbine In Subjects With Inoperable, Previously Untreated, Non-Small Cell Lung Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Lung Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1563\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"levetiracetam\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015769\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/18500360\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077287\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:812\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"desipramine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018200\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D003891\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014599\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy\",\n",
      "            \"schema:MedicalCondition\": \"Vulvar Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010413\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus\",\n",
      "            \"schema:MedicalCondition\": \"Pemphigus\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017108\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Low Dose Chlorambucil Maintenance Vs. No Treatment Following High-Dose Chlorambucil Induction In Patients With Advanced B-Chronic Lymphocytic Leukemia. A Randomized Phase III Study Of The EORTC LG (CLL-3)\",\n",
      "            \"schema:MedicalCondition\": \"Leukemia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018902\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)\",\n",
      "            \"schema:MedicalCondition\": \"Depression\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:790\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"decitabine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019825\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077209\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014586\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent\",\n",
      "            \"schema:MedicalCondition\": \"Prostate Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014196\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Trial of Concurrent Cisplatin/Docetaxel and Radiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non-Small Cell Lung Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Lung Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016952\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study in Patients With Metastatic Colorectal Carcinoma Previously Treated With Oxaliplatin (OXAL) or a Combination of Irinotecan (CPT-11) and OXAL\",\n",
      "            \"schema:MedicalCondition\": \"Colorectal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017147\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma\",\n",
      "            \"schema:MedicalCondition\": \"Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011778\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I Study of Concomitant Therapy With Proteasome Inhibitor PS-341 and Radiation in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck\",\n",
      "            \"schema:MedicalCondition\": \"Squamous Cell Carcinoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019318\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients With Refractory Neoplasms\",\n",
      "            \"schema:MedicalCondition\": \"Lymphoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011765\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"The Effect of Fluoxetine on Measures of Domestic Violence\",\n",
      "            \"schema:MedicalCondition\": \"Domestic Violence\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1556\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"letrozole\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00014638\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077289\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:4633\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"trabectedin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017030\"\n",
      "            },\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077606\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012337\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Trial of ZD1839 (Iressa) in Patients With Advanced Renal Cell Carcinoma\",\n",
      "            \"schema:MedicalCondition\": \"Kidney Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014170\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study Of ZD1839 (NSC 715055) In Newly Diagnosed Patients With Glioblastoma (Grade 4 Astrocytoma)\",\n",
      "            \"schema:MedicalCondition\": \"Adult Giant Cell Glioblastoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:5011\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"aldesleukin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015704\"\n",
      "            },\n",
      "            \"schema:url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019123\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A PHASE II STUDY OF ORAL THALIDOMIDE FOR PATIENTS WITH HIV INFECTION AND KAPOSI'S SARCOMA\",\n",
      "            \"schema:MedicalCondition\": \"Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1725\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"metformin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015626\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D008687\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015548\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)\",\n",
      "            \"schema:MedicalCondition\": \"Alzheimer's Disease\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1890\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"nefazodone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015210\"\n",
      "            },\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015626\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)\",\n",
      "            \"schema:MedicalCondition\": \"Insulin Resistance\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017043\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study of Epothilone Analog BMS-247550 in Patients With Metastatic Gastric Adenocarcinoma Previously Treated With a Taxane\",\n",
      "            \"schema:MedicalCondition\": \"Esophageal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019747\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Colorectal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018200\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Efficacy of Antidepressants in Chronic Back Pain\",\n",
      "            \"schema:MedicalCondition\": \"Back Pain\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2389\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"risperidone\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018668\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018291\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D018967\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015899\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors\",\n",
      "            \"schema:MedicalCondition\": \"Brain and Central Nervous System Tumors\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014001\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)\",\n",
      "            \"schema:MedicalCondition\": \"Schizophrenia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1646\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"mecamylamine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018161\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D008464\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015041\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"PK 0396 - Buprenorphine Dose Escalation Trial\",\n",
      "            \"schema:MedicalCondition\": \"Opioid-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1311\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"glutamine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018109\"\n",
      "            },\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D005973\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017784\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Open-Label Safety Study of Valganciclovir in Patients With CMV Retinitis and AIDS Who Have Complications Due to IV Treatment\",\n",
      "            \"schema:MedicalCondition\": \"Cytomegalovirus Retinitis\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:367\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"bicalutamide\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014586\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012090\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011960\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Phase II Comparison Of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens In Resected Gastric Cancers\",\n",
      "            \"schema:MedicalCondition\": \"Esophageal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019552\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study of MGI-114 in Patients With Recurrent or Persistent Epithelial Ovarian Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Fallopian Tube Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:4392\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"cisplatin\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016874\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012220\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014209\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014196\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00011999\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014313\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017459\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00011960\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002945\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017160\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma\",\n",
      "            \"schema:MedicalCondition\": \"Stage III Adult Soft Tissue Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012584\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Treatment Study of Youth With Comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Anxiety Disorders\",\n",
      "            \"schema:MedicalCondition\": \"Attention Deficit Hyperactivity Disorder\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019760\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of Isolated Hepatic Perfusion With Melphalan Followed By Postoperative Hepatic Arterial Chemotherapy in Patients With Unresectable Colorectal Cancer Metastatic to the Liver\",\n",
      "            \"schema:MedicalCondition\": \"Recurrent Colon Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2405\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"rosiglitazone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018382\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077154\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:4956\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"bevacizumab\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019539\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125085s305lbl.pdf\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000068258\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018083\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen\",\n",
      "            \"schema:MedicalCondition\": \"Tuberculosis\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015886\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Docetaxel (Taxotere) and 5-Fluorouracil As Second- Or Third-Line Chemotherapy In Women With Metastatic Breast Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1540\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"lamotrigine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015106\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077213\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012467\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase II Study of the Safety and Antifungal Activity of Subcutaneous Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) in Conjunction With Standard Therapy in Patients With Acute Cryptococcal Meningitis\",\n",
      "            \"schema:MedicalCondition\": \"Meningitis, Cryptococcal\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017329\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Trial of PS341 (NSC 681239) in Patients With Advanced Renal Cell Carcinoma\",\n",
      "            \"schema:MedicalCondition\": \"Kidney Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010075\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018044\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections\",\n",
      "            \"schema:MedicalCondition\": \"Mycobacterium Infections\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2373\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"ribavirin\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015652\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016081\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D012254\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011804\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Topiramate in the Treatment of Sciatica\",\n",
      "            \"schema:MedicalCondition\": \"Sciatica\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1184\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"floxuridine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019760\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL917\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D005467\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:758\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"cyclophosphamide\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010413\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010400\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017628\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010387\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D003520\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010023\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System\",\n",
      "            \"schema:MedicalCondition\": \"Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017927\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome\",\n",
      "            \"schema:MedicalCondition\": \"McCune Albright Syndrome\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:568\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"celecoxib\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00014404\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000068579\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1982\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"olanzapine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015548\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077152\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1282\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"gefitinib\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014144\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016991\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014170\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012337\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014183\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939\",\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/22037378\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077156\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:639\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"cidofovir\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019240\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077404\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015223\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019773\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients\",\n",
      "            \"schema:MedicalCondition\": \"Carcinoma of the Appendix\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018850\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"5HT3 Antagonism and Auditory Gating in Schizophrenia\",\n",
      "            \"schema:MedicalCondition\": \"Schizophrenia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1508\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"isotretinoin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00014729\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D015474\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018759\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients\",\n",
      "            \"schema:MedicalCondition\": \"Depression\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:434\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"buprenorphine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015041\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002047\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018863\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Methylphenidate Efficacy and Safety in ADHD Preschoolers\",\n",
      "            \"schema:MedicalCondition\": \"Attention Deficit Disorder With Hyperactivity\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015080\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Naltrexone in Treatment of Cocaine Dependence\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:512\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"carmustine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017147\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL513\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002330\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018174\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers\",\n",
      "            \"schema:MedicalCondition\": \"Depression\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018824\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"The Treatment of Late Life Major Depression Complication by Alcohol\",\n",
      "            \"schema:MedicalCondition\": \"Alcoholism\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00013598\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Treatment of Nonalcoholic Steatohepatitis With Pioglitazone\",\n",
      "            \"schema:MedicalCondition\": \"Fatty Liver\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017719\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy\",\n",
      "            \"schema:MedicalCondition\": \"HIV Infections\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1416\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"idebenone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015808\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:144\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"amantadine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015249\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000547\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016016\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I/II Study of Flavopiridol (NSC 649890, IND 46,211) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Poor-Risk Acute Leukemias\",\n",
      "            \"schema:MedicalCondition\": \"Recurrent Adult Acute Lymphoblastic Leukemia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016432\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:438\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"busulfan\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00014469\"\n",
      "            },\n",
      "            \"schema:url\": {\n",
      "                \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D002066\"\n",
      "            }\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015132\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2044\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"paclitaxel\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00011986\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00014599\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://pubmed.ncbi.nlm.nih.gov/11309480\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D017239\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2351\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"raloxifene\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00019500\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820\",\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81\"\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1122\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"exemestane\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016432\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010010\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200374\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2801\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"valganciclovir\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00017784\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL252321\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077562\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:824\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"dexamethasone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00016380\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D003907\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011999\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck\",\n",
      "            \"schema:MedicalCondition\": \"Head and Neck Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012142\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Randomized, Double-Blind, Placebo-Controlled, Phase II Study Of Intravenous CCI-779 Administered Weekly To Patients With Androgen-Independent Prostate Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Prostate Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014183\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study Of ZD1839 (NSC #715055) In Renal Cell Carcinoma Stage IV And Renal Cell Carcinoma Recurrent\",\n",
      "            \"schema:MedicalCondition\": \"Kidney Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015808\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's Ataxia\",\n",
      "            \"schema:MedicalCondition\": \"Friedreich Ataxia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018109\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)\",\n",
      "            \"schema:MedicalCondition\": \"Muscular Dystrophy, Duchenne\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017563\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Prostate Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2337\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"quetiapine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018642\"\n",
      "            },\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3188993\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00012025\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015210\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Efficacy of Nefazodone in Cocaine Dependent Subjects\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2706\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"topiramate\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00011804\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077236\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019968\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity\",\n",
      "            \"schema:MedicalCondition\": \"Stage IVB Adult Soft Tissue Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:4161\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"temsirolimus\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016328\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012142\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:26\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"fluorouracil\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016952\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010088\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010075\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019513\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010062\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D005472\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018642\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia\",\n",
      "            \"schema:MedicalCondition\": \"Schizophrenia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019825\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase I Study of Decitabine Mediated Induction of Tumor Antigen and Tumor Suppressor Gene Expression in Lung Cancer Patients\",\n",
      "            \"schema:MedicalCondition\": \"Esophageal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016393\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Prostate Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018148\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation\",\n",
      "            \"schema:MedicalCondition\": \"Smoking\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2068\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"paroxetine\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018759\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018733\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200609\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D017374\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:480\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"capecitabine\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016926\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019773\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00010023\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1773\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000069287\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016874\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Unspecified Adult Solid Tumor, Protocol Specific\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00013897\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 With Efavirenz; Each in Combination With Fixed Dose Zidovudine-Lamivudine\",\n",
      "            \"schema:MedicalCondition\": \"HIV Infections\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015990\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Phase II Study of Thalidomide in the Treatment of Myelodysplastic Syndromes in Adults: A Clinical and Biologic Study\",\n",
      "            \"schema:MedicalCondition\": \"Chronic Myelomonocytic Leukemia\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010153\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Double-Blind Phase III Clinical Trial to Compare the Effects of a Pre-Operatively Administered Single Dose of \\\"Faslodex\\\" (Long-Acting ICI 182.780) With Placebo on Tumor Recurrence in Pre- and Postmenopausal Women Treated for Operable First Primary Breast Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00019500\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Phase II Trial of Two Doses of Raloxifene in Pre-Menopausal Women at High Risk For Developing Invasive Breast Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00011986\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma\",\n",
      "            \"schema:MedicalCondition\": \"Primary Peritoneal Carcinoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1767\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"methylphenidate\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015223\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015054\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015301\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00018863\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00015067\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012584\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D008774\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2846\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"voriconazole\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00015665\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D065819\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00010010\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer\",\n",
      "            \"schema:MedicalCondition\": \"Breast Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015301\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Methylphenidate Raclopride PET Test\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00018603\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Guanfacine for the Treatment of PTSD\",\n",
      "            \"schema:MedicalCondition\": \"Post-Traumatic Stress Disorder\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00014313\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study to Evaluate the Role of Weekly Cisplatin With Oral Etoposide in Ewing's Sarcoma and Primitive Neuroectodermal Tumor (PNET) With Bone and/or Bone Marrow Metatstatic Disease\",\n",
      "            \"schema:MedicalCondition\": \"Sarcoma\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2179\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"pioglitazone\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00013598\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D000077205\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00017056\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Gastric Adenocarcinoma Previously Treated With A Fluoropyrimidine And/Or Platinum\",\n",
      "            \"schema:MedicalCondition\": \"Esophageal Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:2376\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"rifabutin\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018083\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL444633\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D017828\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015652\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Pilot Study of Low Dose Interleukin-2 (IL-2) With the Addition of Pegylated Interferon (PEG-IFN Alfa-2b) and Ribavirin (RBV) for the Treatment of Hepatitis C Infection in Subjects With HIV Coinfection\",\n",
      "            \"schema:MedicalCondition\": \"HIV Infections\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1517\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"ixabepilone\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017043\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016393\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00017056\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00016965\"\n",
      "                }\n",
      "            ],\n",
      "            \"schema:url\": \"https://pubmed.ncbi.nlm.nih.gov/19010832\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00016380\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis\",\n",
      "            \"schema:MedicalCondition\": \"Cancer\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015769\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness\",\n",
      "            \"schema:MedicalCondition\": \"Bipolar Disorder\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"file:NCT00015067\",\n",
      "            \"@type\": \"schema:MedicalStudy\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"Cocaine-Methylphendidate Interaction Study\",\n",
      "            \"schema:MedicalCondition\": \"Cocaine-Related Disorders\"\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1483\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"irofulven\",\n",
      "            \"schema:study\": [\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00012038\"\n",
      "                },\n",
      "                {\n",
      "                    \"@id\": \"file:NCT00019552\"\n",
      "                }\n",
      "            ]\n",
      "        },\n",
      "        {\n",
      "            \"@id\": \"drug:1343\",\n",
      "            \"@type\": \"schema:Drug\",\n",
      "            \"http://www.w3.org/2000/01/rdf-schema#label\": \"guanfacine\",\n",
      "            \"schema:study\": {\n",
      "                \"@id\": \"file:NCT00018603\"\n",
      "            },\n",
      "            \"schema:url\": [\n",
      "                \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022037s011lbl.pdf\",\n",
      "                {\n",
      "                    \"@id\": \"https://www.ncbi.nlm.nih.gov/mesh/?term=D016316\"\n",
      "                }\n",
      "            ]\n",
      "        }\n",
      "    ]\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "# Serialize the RDF graph in JSON-LD format\n",
    "# jsonld_data = graph.serialize(format='json-ld', indent=4)\n",
    "jsonld_data = graph.serialize(format='json-ld', context=context, indent=4)\n",
    "\n",
    "print(jsonld_data)\n",
    "\n",
    "# print(\"\\n\\n\",len(missing_drugs),\" Drugs not present in TSV:\", missing_drugs)\n",
    "\n",
    "# # Save the result to a JSON-LD file\n",
    "# with open('output.jsonld', 'w') as f:\n",
    "#     f.write(jsonld_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert RDF graph to DOT format\n",
    "dot_file_path = 'output.dot'\n",
    "with open(dot_file_path, 'w') as dot_file:\n",
    "    rdf2dot(graph, dot_file)\n",
    "\n",
    "# Load DOT file and render the graph using Graphviz\n",
    "dot_data = ''\n",
    "with open(dot_file_path, 'r') as dot_file:\n",
    "    dot_data = dot_file.read()\n",
    "\n",
    "graph = pydot.graph_from_dot_data(dot_data)\n",
    "if graph:\n",
    "    svg_file_path = 'output.svg'\n",
    "    graph[0].write_svg(svg_file_path)  # Save the graph as an SVG file"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Projekt-Bielefeld",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
